Big Money Spent On This Ad Campaign, Now Pulled

Stocks are higher on lower oil prices and an upbeat
economic report.

The Conference Board said its index of leading indicators rose 0.2% in
November, reversing a 5-month downtrend.

Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating)
is pulling all Celebrex ads. Last week it was
reported the drug increased risk of heart attack in higher doses. The company
spent $71 in the first 9 months of 2004 advertising the drug. Pfizer will
continue to market the drug to doctors.

Nokia is setting an upbeat tone, expecting 10% growth  in 2005.

Strong sectors are: Gold
(
XAU.X |
Quote |
Chart |
News |
PowerRating)
+0.98%, Utilities
(
UTY.X |
Quote |
Chart |
News |
PowerRating)

+0.94%

Weak sectors are: Pharmaceuticals
(
DRG.X |
Quote |
Chart |
News |
PowerRating)
-0.81% Healthcare
(
HCX.X |
Quote |
Chart |
News |
PowerRating)
-1.83%,
Airlines
(
XAL.X |
Quote |
Chart |
News |
PowerRating)
-0.69%.

Dow +28.45 10,678.15
S&P 500 +2.10 1,196.24
Nasdaq -2.18 2,133.02

The dollar is -0.50 at
81.66

Crude Oil is -0.87 at
45.70

Gold is -0.30 to 441

ce=”Arial” size=”2″ face=”Arial”>Volume is 717 million on the NYSE and
2.35 billion on the Nasdaq.

Market breadth is negative.

NYSE Issues
Advancing 1577 Up Vol 309
Declining 1589 Down Vol 349
Ratio 1.00 1.12
Nasdaq
Advancing 1242 Up Vol 413
Declining 1777 Down Vol 549
Ratio 1.43 1.32

Stocks in the News

Pharmos
(
PARS |
Quote |
Chart |
News |
PowerRating)
said its dexanibrinol was not effective.

Ryder guided lower for 2005.

Audible Systems
(
ADBL |
Quote |
Chart |
News |
PowerRating)
was the subject of downbeat comments in
Barron’s.

Standard Microsystems
(
SMSC |
Quote |
Chart |
News |
PowerRating)
reported 0.03 vs an 0.11 estimate.

JP Morgan raised guidance on Intel by a penny.

Brice Wightman